FDA Accepts Priority Review for Merck’s SAC-TMT Application
The FDA accepted Merck’s biologics license application for SAC-TMT for priority review.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FDA Accepts Merck’s Sac-TMT Application for Priority Review
The FDA accepted Merck’s biologics license application for sac-TMT for priority review.